» Articles » PMID: 39907233

Systemic Inflammation Response Index (SIRI)-based Risk of Pneumonia Following Successful PCI in STEMI Patients

Overview
Journal Ann Med
Publisher Informa Healthcare
Date 2025 Feb 5
PMID 39907233
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In patients with ST-elevation myocardial infarction (STEMI), pulmonary infection after successful primary percutaneous coronary intervention (PCI) is a severe complication that often results in death. It is not known whether there are any predictive markers for the onset of pneumonia in STEMI patients after successful PCI.

Methods: According to whether pneumonia occurred within two weeks of PCI, 619 STEMI patients were divided into pneumonia and nonpneumonia groups. The area under the receiver operating characteristic curve (AUC) was used to assess the predictive accuracy of the SIRI for pneumonia risk following successful PCI. Using a restricted cubic spline (RCS) and multivariate regression analysis, we investigated the relationship between the SIRI and PCI-induced pneumonia.

Results: Patients in the pneumonia group had a significantly greater SIRI than did those in the nonpneumonia group at admission (7.81 ± 7.53 vs. 3.35 ± 3.08,  < 0.001). Patients in the SIRI ≥ 4.04 group exhibited greater vulnerability to pneumonia after successful PCI than did those in the SIRI < 4.04 group (OR: 5.20, 95% CI: 3.53-7.72,  < 0.001). According to the ROC curve, the SIRI is highly predictive of pneumonia after PCI for STEMI patients, with an AUC of 0.766 (95% CI: 0.724-0.808). As the SIRI increased, the pneumonia risk increased in the RCS model.

Conclusion: As a result of PCI for STEMI patients, the SIRI is a good indicator of pneumonia risk. The likelihood of pneumonia occurring in STEMI patients after PCI generally increases with increasing SIRI.

References
1.
Parenica J, Jarkovsky J, Malaska J, Mebazaa A, Gottwaldova J, Helanova K . Infectious Complications and Immune/Inflammatory Response in Cardiogenic Shock Patients: A Prospective Observational Study. Shock. 2016; 47(2):165-174. PMC: 5266423. DOI: 10.1097/SHK.0000000000000756. View

2.
Eisen A, Giugliano R, Braunwald E . Updates on Acute Coronary Syndrome: A Review. JAMA Cardiol. 2016; 1(6):718-30. DOI: 10.1001/jamacardio.2016.2049. View

3.
Xin Y, Zhang X, Li Y, Yang Y, Chen Y, Wang Y . A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2021; 45(1):43-53. DOI: 10.1007/s00270-021-02965-4. View

4.
Wheeler J, Mussolino M, Gillum R, Danesh J . Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J. 2004; 25(15):1287-92. DOI: 10.1016/j.ehj.2004.05.002. View

5.
Cinar T, Saylik F, Akbulut T, Korkmaz Y, Cicek V, Asal S . Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients. Angiology. 2022; 74(4):357-364. DOI: 10.1177/00033197221105753. View